<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: My Advice for Pharma Social Media Programs: Ignore the Consumer</title>
	<atom:link href="http://prforpharma.com/2009/12/04/my-advice-for-pharma-social-media-programs-ignore-the-consumer/feed/" rel="self" type="application/rss+xml" />
	<link>http://prforpharma.com/2009/12/04/my-advice-for-pharma-social-media-programs-ignore-the-consumer/#utm_source=feed&#038;utm_medium=feed&#038;utm_campaign=feed</link>
	<description>Discussions about social media, PR and marketing for pharmaceutical companies</description>
	<lastBuildDate>Thu, 19 Jan 2012 21:23:35 +0000</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.1.1</generator>
	<item>
		<title>By: Chris Iafolla</title>
		<link>http://prforpharma.com/2009/12/04/my-advice-for-pharma-social-media-programs-ignore-the-consumer/comment-page-1/#comment-936</link>
		<dc:creator>Chris Iafolla</dc:creator>
		<pubDate>Wed, 09 Dec 2009 01:59:10 +0000</pubDate>
		<guid isPermaLink="false">http://prforpharma.com/?p=85#comment-936</guid>
		<description>&lt;span class=&quot;topsy_trackback_comment&quot;&gt;&lt;span class=&quot;topsy_twitter_username&quot;&gt;&lt;span class=&quot;topsy_trackback_content&quot;&gt;Interesting commentary on my post from last week on why pharma should ignore the consumer in social media engagements: http://bit.ly/8IvQID&lt;/span&gt;&lt;/span&gt;</description>
		<content:encoded><![CDATA[<p><span class="topsy_trackback_comment"><span class="topsy_twitter_username"><span class="topsy_trackback_content">Interesting commentary on my post from last week on why pharma should ignore the consumer in social media engagements: <a href="http://bit.ly/8IvQID" rel="nofollow">http://bit.ly/8IvQID</a></span></span></span></p>
]]></content:encoded>
	</item>
	<item>
		<title>By: cdebie</title>
		<link>http://prforpharma.com/2009/12/04/my-advice-for-pharma-social-media-programs-ignore-the-consumer/comment-page-1/#comment-937</link>
		<dc:creator>cdebie</dc:creator>
		<pubDate>Mon, 07 Dec 2009 18:45:51 +0000</pubDate>
		<guid isPermaLink="false">http://prforpharma.com/?p=85#comment-937</guid>
		<description>&lt;span class=&quot;topsy_trackback_comment&quot;&gt;&lt;span class=&quot;topsy_twitter_username&quot;&gt;&lt;span class=&quot;topsy_trackback_content&quot;&gt;cdebie
  
@PRforPharma:My Advice for Pharma Social Media Programs: Ignore the Consumer http://bit.ly/7cFuvW&lt;/span&gt;&lt;/span&gt;</description>
		<content:encoded><![CDATA[<p><span class="topsy_trackback_comment"><span class="topsy_twitter_username"><span class="topsy_trackback_content">cdebie</p>
<p>@PRforPharma:My Advice for Pharma Social Media Programs: Ignore the Consumer <a href="http://bit.ly/7cFuvW" rel="nofollow">http://bit.ly/7cFuvW</a></span></span></span></p>
]]></content:encoded>
	</item>
	<item>
		<title>By: cdebie</title>
		<link>http://prforpharma.com/2009/12/04/my-advice-for-pharma-social-media-programs-ignore-the-consumer/comment-page-1/#comment-938</link>
		<dc:creator>cdebie</dc:creator>
		<pubDate>Mon, 07 Dec 2009 18:42:40 +0000</pubDate>
		<guid isPermaLink="false">http://prforpharma.com/?p=85#comment-938</guid>
		<description>&lt;span class=&quot;topsy_trackback_comment&quot;&gt;&lt;span class=&quot;topsy_twitter_username&quot;&gt;&lt;span class=&quot;topsy_trackback_content&quot;&gt;My Advice for Pharma Social Media Programs: Ignore the Consumer http://bit.ly/7cFuvW via @AddToAny&lt;/span&gt;&lt;/span&gt;</description>
		<content:encoded><![CDATA[<p><span class="topsy_trackback_comment"><span class="topsy_twitter_username"><span class="topsy_trackback_content">My Advice for Pharma Social Media Programs: Ignore the Consumer <a href="http://bit.ly/7cFuvW" rel="nofollow">http://bit.ly/7cFuvW</a> via @AddToAny</span></span></span></p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Danny Lieberman</title>
		<link>http://prforpharma.com/2009/12/04/my-advice-for-pharma-social-media-programs-ignore-the-consumer/comment-page-1/#comment-322</link>
		<dc:creator>Danny Lieberman</dc:creator>
		<pubDate>Mon, 07 Dec 2009 13:42:43 +0000</pubDate>
		<guid isPermaLink="false">http://prforpharma.com/?p=85#comment-322</guid>
		<description>Social software is not just about end users. There are significant regulatory and business reasons for pharmas not to want to get into the open social media space with patients.

My advice to pharma is change their business model with their primary customers - their doctors and the rest of the clinical care team.    There is fertile opportunity to use social software in the doctor- medical sales rep/medical area interaction without reaching all the way down the food chain to end user patients.

Danny</description>
		<content:encoded><![CDATA[<p>Social software is not just about end users. There are significant regulatory and business reasons for pharmas not to want to get into the open social media space with patients.</p>
<p>My advice to pharma is change their business model with their primary customers &#8211; their doctors and the rest of the clinical care team.    There is fertile opportunity to use social software in the doctor- medical sales rep/medical area interaction without reaching all the way down the food chain to end user patients.</p>
<p>Danny</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: uri</title>
		<link>http://prforpharma.com/2009/12/04/my-advice-for-pharma-social-media-programs-ignore-the-consumer/comment-page-1/#comment-310</link>
		<dc:creator>uri</dc:creator>
		<pubDate>Sun, 06 Dec 2009 10:48:31 +0000</pubDate>
		<guid isPermaLink="false">http://prforpharma.com/?p=85#comment-310</guid>
		<description>Very interesting POV. but you dont elaborate on the practical side - what would be a good wxample of messaging the customer and not a consumer - do you think this also apply to OTC?</description>
		<content:encoded><![CDATA[<p>Very interesting POV. but you dont elaborate on the practical side &#8211; what would be a good wxample of messaging the customer and not a consumer &#8211; do you think this also apply to OTC?</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Chris Iafolla</title>
		<link>http://prforpharma.com/2009/12/04/my-advice-for-pharma-social-media-programs-ignore-the-consumer/comment-page-1/#comment-304</link>
		<dc:creator>Chris Iafolla</dc:creator>
		<pubDate>Sat, 05 Dec 2009 15:02:22 +0000</pubDate>
		<guid isPermaLink="false">http://prforpharma.com/?p=85#comment-304</guid>
		<description>Pete, you raise an interesting point.  But one point of clarification first: I think you are highlighting the point I am trying to make in defining consumers.  In general, consumers are a statistical entity.  As you said, in the case of pharma, the real consumer is the patient.  I agree 100%.  The patient is where the focus should be and not on the statistical body of people.  

But your point on the different customers that are in the mix is interesting.  You are right, it used to be how to get a doctor to write a prescription and ensure it is filled was the name of the game.  That game has changed.  There are a number of new customers in the mix that complicate the messaging and communications process.  I would venture to say that only highlights the need for social media engagement strategies.  With such a segmented audience, a mass marketing type of approach is bound to fail.  A social media engagement strategy that tailors its efforts to each audience is far more likely to provide value.</description>
		<content:encoded><![CDATA[<p>Pete, you raise an interesting point.  But one point of clarification first: I think you are highlighting the point I am trying to make in defining consumers.  In general, consumers are a statistical entity.  As you said, in the case of pharma, the real consumer is the patient.  I agree 100%.  The patient is where the focus should be and not on the statistical body of people.  </p>
<p>But your point on the different customers that are in the mix is interesting.  You are right, it used to be how to get a doctor to write a prescription and ensure it is filled was the name of the game.  That game has changed.  There are a number of new customers in the mix that complicate the messaging and communications process.  I would venture to say that only highlights the need for social media engagement strategies.  With such a segmented audience, a mass marketing type of approach is bound to fail.  A social media engagement strategy that tailors its efforts to each audience is far more likely to provide value.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Reda T. Hojeij</title>
		<link>http://prforpharma.com/2009/12/04/my-advice-for-pharma-social-media-programs-ignore-the-consumer/comment-page-1/#comment-939</link>
		<dc:creator>Reda T. Hojeij</dc:creator>
		<pubDate>Sat, 05 Dec 2009 14:25:10 +0000</pubDate>
		<guid isPermaLink="false">http://prforpharma.com/?p=85#comment-939</guid>
		<description>&lt;span class=&quot;topsy_trackback_comment&quot;&gt;&lt;span class=&quot;topsy_twitter_username&quot;&gt;&lt;span class=&quot;topsy_trackback_content&quot;&gt;My Advice for Pharma Social Media Programs: Ignore the Consumer http://bit.ly/7cFuvW via @AddToAny&lt;/span&gt;&lt;/span&gt;</description>
		<content:encoded><![CDATA[<p><span class="topsy_trackback_comment"><span class="topsy_twitter_username"><span class="topsy_trackback_content">My Advice for Pharma Social Media Programs: Ignore the Consumer <a href="http://bit.ly/7cFuvW" rel="nofollow">http://bit.ly/7cFuvW</a> via @AddToAny</span></span></span></p>
]]></content:encoded>
	</item>
	<item>
		<title>By: FGO Folini</title>
		<link>http://prforpharma.com/2009/12/04/my-advice-for-pharma-social-media-programs-ignore-the-consumer/comment-page-1/#comment-940</link>
		<dc:creator>FGO Folini</dc:creator>
		<pubDate>Sat, 05 Dec 2009 13:49:45 +0000</pubDate>
		<guid isPermaLink="false">http://prforpharma.com/?p=85#comment-940</guid>
		<description>&lt;span class=&quot;topsy_trackback_comment&quot;&gt;&lt;span class=&quot;topsy_twitter_username&quot;&gt;&lt;span class=&quot;topsy_trackback_content&quot;&gt;Customers, not consumers: but is this really the target of BigPharma in Social Media Marketing?  http://tiny.cc/cVucu&lt;/span&gt;&lt;/span&gt;</description>
		<content:encoded><![CDATA[<p><span class="topsy_trackback_comment"><span class="topsy_twitter_username"><span class="topsy_trackback_content">Customers, not consumers: but is this really the target of BigPharma in Social Media Marketing?  <a href="http://tiny.cc/cVucu" rel="nofollow">http://tiny.cc/cVucu</a></span></span></span></p>
]]></content:encoded>
	</item>
	<item>
		<title>By: kalemakalema (Reda T. Hojeij)</title>
		<link>http://prforpharma.com/2009/12/04/my-advice-for-pharma-social-media-programs-ignore-the-consumer/comment-page-1/#comment-299</link>
		<dc:creator>kalemakalema (Reda T. Hojeij)</dc:creator>
		<pubDate>Sat, 05 Dec 2009 09:28:48 +0000</pubDate>
		<guid isPermaLink="false">http://prforpharma.com/?p=85#comment-299</guid>
		<description>&lt;strong&gt;Twitter Comment&lt;/strong&gt;
&lt;a href=&quot;http://twitter.com/kalemakalema&quot; title=&quot;Twitter Comment&quot; rel=&quot;nofollow&quot;&gt;
&lt;div class=&quot;ccimg1&quot; title=&quot;kalemakalema (Reda T. Hojeij)&quot; style=&quot;float:left;margin-right:10px;padding:0;width:60px;height:60px;&quot;&gt;
&lt;img name=&quot;cc_image&quot; title=&quot;kalemakalema (Reda T. Hojeij)&quot; style=&quot;float:left;margin-right:10px;padding:0;width:50px;height:50px;&quot; src=&quot;http://purl.org/net/spiurl/kalemakalema&quot;&gt;
&lt;/div&gt;
&lt;/a&gt;
My Advice for Pharma Social Media Programs: Ignore the Consumer [link to post] via @AddToAny&lt;br /&gt;&lt;br /&gt; - &lt;a href=&quot;http://chatcatcher.com&quot; target=&quot;_blank&quot; rel=&quot;nofollow&quot;&gt;Posted using Chat Catcher&lt;/a&gt; </description>
		<content:encoded><![CDATA[<p><strong>Twitter Comment</strong><br />
<a href="http://twitter.com/kalemakalema" title="Twitter Comment" rel="nofollow"></p>
<div class="ccimg1" title="kalemakalema (Reda T. Hojeij)" style="float:left;margin-right:10px;padding:0;width:60px;height:60px;">
<img name="cc_image" title="kalemakalema (Reda T. Hojeij)" style="float:left;margin-right:10px;padding:0;width:50px;height:50px;" src="http://purl.org/net/spiurl/kalemakalema"/>
</div>
<p></a><br />
My Advice for Pharma Social Media Programs: Ignore the Consumer [link to post] via @AddToAny</p>
<p> &#8211; <a href="http://chatcatcher.com" target="_blank" rel="nofollow">Posted using Chat Catcher</a></p>
]]></content:encoded>
	</item>
	<item>
		<title>By: uberVU - social comments</title>
		<link>http://prforpharma.com/2009/12/04/my-advice-for-pharma-social-media-programs-ignore-the-consumer/comment-page-1/#comment-298</link>
		<dc:creator>uberVU - social comments</dc:creator>
		<pubDate>Sat, 05 Dec 2009 08:54:13 +0000</pubDate>
		<guid isPermaLink="false">http://prforpharma.com/?p=85#comment-298</guid>
		<description>&lt;strong&gt;Social comments and analytics for this post...&lt;/strong&gt;

This post was mentioned on Twitter by Chris Iafolla: The case for ignoring the consumer in your pharma social media strategy: http://bit.ly/8IvQID...</description>
		<content:encoded><![CDATA[<p><strong>Social comments and analytics for this post&#8230;</strong></p>
<p>This post was mentioned on Twitter by Chris Iafolla: The case for ignoring the consumer in your pharma social media strategy: <a href="http://bit.ly/8IvQID.." rel="nofollow">http://bit.ly/8IvQID..</a>.</p>
]]></content:encoded>
	</item>
</channel>
</rss>

